ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1008

Identifying Inflammatory Arthritis Ambulatory Care Service Model Enhancements Needed to Reduce Avoidable Emergency Department Use

Emilie Pianarosa1, Pamela Roach1, Patrick McLane2, Meghan Elliott1, Brian Holroyd3, Shanon McQuitty4, Steven Katz3, Nazret Russon2, Katie Lin1, Claire Barber1 and Cheryl Barnabe1, 1University of Calgary, Calgary, AB, Canada, 2Alberta Health Services, Edmonton, AB, Canada, 3University of Alberta, Edmonton, AB, Canada, 4Arthritis Research Canada, Vancouver, BC, Canada

Meeting: ACR Convergence 2023

Keywords: Access to care, gout, Health Services Research, Qualitative Research, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 13, 2023

Title: (0993–1012) Health Services Research Poster II

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Emergency departments (ED) become a location for non-urgent care when ambulatory care systems are not sufficient. We aim to describe contributing factors to the decision taken by persons with inflammatory arthritis (IA) to present to the ED, their experiences of ED care, and propose enhancements in ambulatory models of care to better support patients and improve system efficiency.

Methods: An invitation to complete an online survey was distributed by the health authority in October 2021 and March 2022 to a sample of individuals with an IA condition who had visited an ED within the previous year. Descriptive statistics were used to summarize quantitative data. Thematic analysis of free text responses was conducted to contextualize decision making and experiences of ED care, and generate system-level recommendations to reduce avoidable ED use.

Results: 82 persons (48% RA, 12% PsA, 6% SpA, 34% Gout; 63% aged 16-55 years; 48% female; 50% urban residents) completed the survey. Over 1/3 (37%) of visits were for arthritis flare or other musculoskeletal symptoms, with other primary symptoms being chest pain (15%), injury (12%) and infection (11%). Of all visits, 28% of persons reported they proceeded directly to the ED, 32% made a return visit, and 36% were completed after accessing ambulatory care, primarily a primary care provider. For visits specific to arthritis flare or other musculoskeletal symptoms, 19% of patients proceeded directly to the ED as they could not access ambulatory care (after business hours, or call to provider not returned), 36% were a return visit of which 64% were for symptoms being unresolved or worsening and with 27% not being able to follow-up with their rheumatologist. For 39% they had accessed primary or specialty care for assessment and management first but then presented to the ED anyways. The rheumatology service was contacted by the ED provider in 9% of events of patients presenting with arthritis flare. Challenges in healthcare system coordination, system processes and pressures, and communication and relationality between IA patients and healthcare providers led to negative experiences of ED care (Table 1). After an ED visit patients had remaining concerns about not having been assessed comprehensively, and not having the cause of their symptoms being explained to them. They felt they were being discharged too soon, did not have a symptom management plan, and had the responsibility to coordinate multiple further assessments with different ambulatory providers. They perceived symptoms were not being appropriately attributed to their arthritis condition, Recommendations to reduce avoidable ED use include improving access to rheumatology care for both initial visits and urgent concerns, introducing initiatives for improved ambulatory care coordination and service delivery, resourcing EDs at appropriate levels to provide quality care, and to enhance provider education about arthritis condition assessment and management.

Conclusion: We present initial recommendations to develop systems and procedures to reduce the need for ED use by IA patients. Modifying current models of care may improve patient outcomes while simultaneously decreasing utilization and cost to the healthcare system.

Supporting image 1

Themes and Representative Quotes for Emergency Department Experience


Disclosures: E. Pianarosa: None; P. Roach: None; P. McLane: None; M. Elliott: None; B. Holroyd: None; S. McQuitty: None; S. Katz: None; N. Russon: None; K. Lin: None; C. Barber: None; C. Barnabe: None.

To cite this abstract in AMA style:

Pianarosa E, Roach P, McLane P, Elliott M, Holroyd B, McQuitty S, Katz S, Russon N, Lin K, Barber C, Barnabe C. Identifying Inflammatory Arthritis Ambulatory Care Service Model Enhancements Needed to Reduce Avoidable Emergency Department Use [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/identifying-inflammatory-arthritis-ambulatory-care-service-model-enhancements-needed-to-reduce-avoidable-emergency-department-use/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identifying-inflammatory-arthritis-ambulatory-care-service-model-enhancements-needed-to-reduce-avoidable-emergency-department-use/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology